Pharma Stocks
-
Did EMA’s Positive Hopledo Ruling Just Shift Amneal Pharmaceuticals’ (AMRX) Investment Narrative?
Zambon and Amneal Pharmaceuticals recently announced that the EMA’s Committee for Medicinal Products for Human Use issued a positive opinion…
Read More » -
ARS Pharmaceuticals Announces CEO Succession
ARS Pharmaceuticals, Inc. Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn…
Read More » -
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
Senior management elects restricted common stock at $0.27 per share in lieu of repayment of amounts owed, including more than…
Read More » -
Is Amylyx Pharmaceuticals (AMLX) A Bargain Following Russell Index Removals?
Amylyx Pharmaceuticals (AMLX) has just been removed from several Russell equity indexes, a technical event that can prompt index tracking…
Read More » -
Why Island Pharmaceuticals (ASX:ILA) Shares Are Trading Higher On Tuesday?
Highlights • Island Pharmaceuticals shares rose 26.67% on 7 July 2026 after announcing government and regulatory approvals for Galidesivir use…
Read More » -
Crinetics Pharmaceuticals Surges After Vertex Agrees to Buy Company for $85 a Share
Crinetics Pharmaceuticals (CRNX) is up 98.8% today. Here is some analysis on what might have caused this price movement. Analysis:…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)
Zealand Pharma Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)…
Read More » -
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
Over the past few years, Eli Lilly (LLY +1.35%) has been offering investors a unique combination of safety and growth.…
Read More » -
Takeda Pharmaceutical (TSE:4502) Is Up 5.3% After New Insilico AI Drug Discovery Deal – Has The Bull Case Changed?
On July 2, 2026, Insilico Medicine announced a collaboration with Takeda Pharmaceutical to apply its Pharma.AI platform to discover and…
Read More » -
Index Exit and Early ALS Data Could Be A Game Changer For Amylyx Pharmaceuticals (AMLX)
Amylyx Pharmaceuticals was removed in late June 2026 from multiple Russell equity indexes, while also reporting initial Phase 1 LUMINA…
Read More »